How long can you use weight loss injections — and what happens when you stop?

The biggest myth: weight loss injections are a short course with a set finish line

Most people approaching these medicines assume there is a standard treatment length, eight weeks, twelve weeks, six months, done. That is not how GLP-1 and dual-agonist medicines are designed or licensed. Tirzepatide (Mounjaro) and semaglutide (Wegovy) are licensed for ongoing weight management alongside lifestyle changes. There is no printed expiry on the course the way there is with, say, a round of antibiotics.

The confusion partly comes from how these medicines are talked about publicly. People hear phrases like "a twelve-week programme" from services that bundle treatment into quarterly blocks for billing purposes. The medicine itself is weekly and continuous. The question of how long you can be on weight loss injections is genuinely clinical, not administrative.

What the licence actually says: both medicines should be reviewed if meaningful weight loss has not occurred. NICE's appraisal of tirzepatide (TA1026) recommends stopping if less than 5% body weight is lost after six months at the highest tolerated dose. That is a response checkpoint, not a time limit.

What "long-term" looks like in practice, and what happens when you stop

The SURMOUNT-1 trial ran for 72 weeks at the higher doses of tirzepatide. Participants in extension studies who stopped the medicine regained a significant portion of lost weight over the following months. That pattern is not unique to tirzepatide; it reflects the underlying biology. Obesity is a chronic condition, and for many people the medicine is managing it the way antihypertensives manage blood pressure. Stopping does not reset the clock to before you started, it changes the hormonal signals that had been suppressing appetite.

This is not a reason to avoid these medicines. It is a reason to go in with clear expectations and a plan. A prescriber who has reviewed how long you intend to stay on weight loss injections will help you think through what weight maintenance looks like before you begin titrating down, not after. Lifestyle habits built during treatment (portion awareness, protein intake, regular movement) tend to be what softens the rebound.

One practical note: some people time their treatment start around a predictable routine (post-holiday, after a big work deadline, when a payday makes the ongoing cost manageable). That kind of planning, applied to duration too, is sensible. What matters is that any pause or stop is discussed with your prescriber first, not decided on a quiet Tuesday.

NHS rules versus private prescribing, they are not the same thing

The two-year limit you will see mentioned in several places applies to NHS prescribing of Wegovy under NICE technology appraisal TA875. NICE recommends semaglutide for weight management for a maximum of two years within a specialist service. That is a funding and commissioning decision by NICE for NHS England, it does not mean semaglutide becomes unsafe or unlicensed at month 25.

Privately, a prescriber can continue treatment beyond two years if the clinical picture supports it. Mounjaro, under a different NICE appraisal (TA1026), has no equivalent time cap in the NHS recommendations either, the review trigger is clinical response, not a calendar date. If you are trying to understand how long you have to take weight loss injections before you can stop, that is a different conversation again, and one worth having openly with a prescriber.

At nume, every repeat order involves a fresh clinical review by a GPhC-registered prescriber. There is no auto-renewal. A clinician looks at your progress before anything is dispensed, which means duration is an active, reviewed decision, not something that drifts on unchecked. You can read about our clinical team's approach on the clinical team page.

Practical guidance on reviewing duration with your prescriber

If you are thinking about how long you take weight loss injections, these are the questions worth raising at your next review. Has your weight plateaued at your current dose? Are side effects affecting quality of life? Have you reached a clinically stable point where tapering could be explored? Is your lifestyle resilient enough to support maintenance without pharmacological appetite suppression?

No single answer fits everyone. Someone managing obesity alongside cardiovascular risk factors may benefit from long-term treatment in the same way a person with high blood pressure stays on their medication. Someone who has reached their goal weight and built strong habits may work with their prescriber toward a gradual step-down. Both are valid. Neither should be decided alone or in a hurry.

If you want to explore your options with a prescriber who will review your situation properly, you can find current weight loss injection pricing on our treatment page, or check our frequently asked questions for more on the process. When you are ready, start your free consultation and a GPhC-registered prescriber will review your case the same day.